JP2020517260A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020517260A5 JP2020517260A5 JP2019556928A JP2019556928A JP2020517260A5 JP 2020517260 A5 JP2020517260 A5 JP 2020517260A5 JP 2019556928 A JP2019556928 A JP 2019556928A JP 2019556928 A JP2019556928 A JP 2019556928A JP 2020517260 A5 JP2020517260 A5 JP 2020517260A5
- Authority
- JP
- Japan
- Prior art keywords
- replaced
- seq
- modified
- asn
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1706406.4A GB201706406D0 (en) | 2017-04-21 | 2017-04-21 | Method of treatment |
| GB1706406.4 | 2017-04-21 | ||
| PCT/EP2018/060240 WO2018193121A1 (en) | 2017-04-21 | 2018-04-20 | Coversin variants lacking c5 binding |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020517260A JP2020517260A (ja) | 2020-06-18 |
| JP2020517260A5 true JP2020517260A5 (https=) | 2021-05-27 |
| JP7183180B2 JP7183180B2 (ja) | 2022-12-05 |
Family
ID=58795719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019556928A Active JP7183180B2 (ja) | 2017-04-21 | 2018-04-20 | Ｃ５結合性を欠失したコバーシンバリアント |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11214602B2 (https=) |
| EP (1) | EP3612207B1 (https=) |
| JP (1) | JP7183180B2 (https=) |
| KR (1) | KR102630702B1 (https=) |
| CN (1) | CN110799207B (https=) |
| AU (1) | AU2018253961B2 (https=) |
| CA (1) | CA3060336A1 (https=) |
| ES (1) | ES2980279T3 (https=) |
| GB (1) | GB201706406D0 (https=) |
| IL (1) | IL269856B2 (https=) |
| PL (1) | PL3612207T3 (https=) |
| WO (1) | WO2018193121A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018193120A1 (en) * | 2017-04-21 | 2018-10-25 | Volution Immuno Pharmaceuticals Sa | Coversin for the treatment of cicatrising eye inflammatory disorders |
| GB201706406D0 (en) | 2017-04-21 | 2017-06-07 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| US11730792B2 (en) | 2017-04-21 | 2023-08-22 | Volution Immuno Pharmaceuticals Sa | Coversin (OmCI) for the treatment of autoimmune blistering diseases: bullous pemphigoid (BP) and epidermolysis bullosa acquisita (EBA) |
| JP7629394B2 (ja) * | 2018-09-10 | 2025-02-13 | ヴォリューション イミュノ ファーマシューティカルズ エスエイ | リウマチ性疾患の治療に使用するためのコバーシン |
| GB201905810D0 (en) | 2019-04-25 | 2019-06-05 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| US20220370556A1 (en) | 2019-09-27 | 2022-11-24 | Volution Immuno Pharmaceuticals Sa | Method of Treatment |
| GB202218084D0 (en) | 2022-12-01 | 2023-01-18 | Volution Immuno Pharmaceuticals Sa | Fusion proteins |
| GB202408081D0 (en) | 2024-06-06 | 2024-07-24 | Volution Immuno Pharmaceuticals Sa | Methods of removing impurities |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001241156A1 (en) * | 2000-03-21 | 2001-10-03 | Yamanouchi Pharmaceutical Co..Ltd. | Novel leukotriene b4 receptor |
| US7452965B2 (en) * | 2002-04-05 | 2008-11-18 | University Of Utah Research Foundation | Colon tumor specific binding peptides |
| EP1629098B1 (en) | 2003-06-02 | 2009-04-01 | Varleigh Limited | Complement inhibitors from ticks |
| EP1739078A1 (de) | 2005-05-30 | 2007-01-03 | Jerini AG | C5a-Rezeptor-Antagonisten |
| GB0518443D0 (en) * | 2005-09-09 | 2005-10-19 | Evolutec Ltd | Method of treating myasthenia gravis |
| AU2008228247A1 (en) | 2007-03-22 | 2008-09-25 | Novartis Ag | C5 antigens and uses thereof |
| GB0802116D0 (en) * | 2008-02-05 | 2008-03-12 | Natural Enviromental Res Counc | Treatment |
| GB0906779D0 (en) | 2009-04-20 | 2009-06-03 | Natural Environment Res Council | Composition |
| EP3524258B1 (en) | 2011-06-22 | 2025-10-01 | Apellis Pharmaceuticals, Inc. | Methods of treating chronic disorders with complement inhibitors |
| GB201410031D0 (en) * | 2014-06-05 | 2014-07-16 | Isis Innovation | Polypeptides and uses thereof |
| CA2988313A1 (en) * | 2015-06-08 | 2016-12-15 | Volution Immuno Pharmaceuticals Sa | Ornithodoros moubata complement inhibitor for use in the treatment of acute graft versus host disease |
| WO2018193120A1 (en) * | 2017-04-21 | 2018-10-25 | Volution Immuno Pharmaceuticals Sa | Coversin for the treatment of cicatrising eye inflammatory disorders |
| GB201706406D0 (en) | 2017-04-21 | 2017-06-07 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| US11730792B2 (en) | 2017-04-21 | 2023-08-22 | Volution Immuno Pharmaceuticals Sa | Coversin (OmCI) for the treatment of autoimmune blistering diseases: bullous pemphigoid (BP) and epidermolysis bullosa acquisita (EBA) |
-
2017
- 2017-04-21 GB GBGB1706406.4A patent/GB201706406D0/en not_active Ceased
-
2018
- 2018-04-20 CN CN201880040770.5A patent/CN110799207B/zh active Active
- 2018-04-20 JP JP2019556928A patent/JP7183180B2/ja active Active
- 2018-04-20 KR KR1020197031710A patent/KR102630702B1/ko active Active
- 2018-04-20 PL PL18719169.7T patent/PL3612207T3/pl unknown
- 2018-04-20 AU AU2018253961A patent/AU2018253961B2/en active Active
- 2018-04-20 ES ES18719169T patent/ES2980279T3/es active Active
- 2018-04-20 IL IL269856A patent/IL269856B2/en unknown
- 2018-04-20 US US16/603,357 patent/US11214602B2/en active Active
- 2018-04-20 CA CA3060336A patent/CA3060336A1/en active Pending
- 2018-04-20 WO PCT/EP2018/060240 patent/WO2018193121A1/en not_active Ceased
- 2018-04-20 EP EP18719169.7A patent/EP3612207B1/en active Active
-
2021
- 2021-11-18 US US17/529,534 patent/US20230002456A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020517260A5 (https=) | ||
| JP2025063029A5 (https=) | ||
| JP2023518596A5 (https=) | ||
| JP2018171063A5 (https=) | ||
| JP2020500015A5 (https=) | ||
| JP2023544834A5 (https=) | ||
| JP2007513634A5 (https=) | ||
| JP2025184979A5 (https=) | ||
| RU2010122053A (ru) | Иммуносупрессорные полипептиды и нуклеиновые кислоты | |
| KR20020026558A (ko) | 키메라성 폴리펩타이드, 이의 제조 방법 및 용도 | |
| JP2012520059A5 (https=) | ||
| JPH04281790A (ja) | Ｄｎａおよびその用途 | |
| JP2023040169A5 (https=) | ||
| US11174298B2 (en) | Preparation and use of ginsentides and ginsentide-like peptides | |
| JP2014506450A5 (https=) | ||
| JP2015523373A (ja) | ｅＩＦ４Ｅを標的化するための細胞浸透性ペプチド | |
| JP7677901B2 (ja) | グルカゴン様ペプチド－１（ｇｌｐ－１）受容体アゴニストとその類似体の製造プロセス | |
| TW200844230A (en) | Signaling peptides | |
| WO2021083301A1 (zh) | 多肽的生产和纯化方法 | |
| JP2026035742A5 (https=) | ||
| JP2005511038A5 (https=) | ||
| JPWO2020027010A5 (https=) | ||
| CN102816213A (zh) | 使用固相和液相组合技术制备普兰林肽的方法 | |
| WO2016058547A1 (zh) | 高活性的肿瘤抑制剂及其制法和应用 | |
| JP2020127419A5 (https=) |